Exciting News from HT-Advance! 

We’re thrilled to announce that the first patient had been included in the HT-PREDICT study end of May 2024, marking a significant milestone for our consortium. 🌟

Radboudumc has led the way by successfully enrolling the first patient, setting the stage for a promising journey ahead. A special shoutout to @Joost Rutten, PI of the HT-PREDICT study, and Wendy van Haaren-Vorstenbosch Haaren for their dedication in conducting the screening visit with the patient.

As many of you know, patient recruitment can be one of the most challenging aspects of research. However, through our collaboration with Henk Schers and the Radboudumc Academisch Huisartsen Netwerk (AHN), we’ve been able to tap into primary care resources, ensuring access to patients with primary hypertension without extensive health problems. A huge thank you to everyone involved for their invaluable contributions and support.

 

photo by Teun Keijzer

Annual consortium meeting 2024 Zürich

Last week HT-Advance partners met at the University of Zürich for their annual consortium meeting. Fruitful days of discussion and preparation of notably our first upcoming clinical trial!

Executive Committee (ExCom) meeting of HT-Advance  26th October 2023

The second ExCom meeting took place, in person, in Rotterdam and was hold in an extended way, inviting all partners of the consortium as it was deemed important in the beginning of the project to meet in person more often than just once a year . The first ExCom meeting had taken place online in June 2023.

This first year sets the stone for the Virtual Research Environment that will be build up at UNIVDUN and  needs especially intensive discussions between clinicians, omic partners and UNIVDUN. Those discussions have been at the heart of this ExCom meeting.

HT-Advance kick-of meeting took place on 8th March 2023 in Torino

HT-Advance project started officially on 1st of March 2023 and partners gathered on 8th and 9th March 2023 to discuss the workplan of the six years of the project and kick-off the first tasks. The meeting was hosted by partner UNITO on the premises of the University of Torino.

Exciting News from HT-Advance! PREDICT study

28 August 2024
Exciting News from HT-Advance!  We're thrilled to announce that the first patient had been included in the HT-PREDICT study end of May 2024, marking a significant milestone for our consortium. 🌟 Radboudumc has led the way by successfully enrolling the first patient, setting the stage for a promising journey ahead. A special shoutout to @Joost [...]